Magnofarma
FDA import alert and refusal historyBogota, ColombiaFEI 3008172752
As of October 26, 2026, Magnofarma is not on any FDA import alert in SupplierRadar's records; FDA refused 1 of its shipment line on July 10, 2026, most often for unapproved new drug (UNAPPROVED).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Vitamin c (ascorbic acid) · UNAPPROVED
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Magnofarma
1 record, newest first. Each line links to the FDA page it came from.
2026
- Import refusalRefused, Vitamin c (ascorbic acid)UNAPPROVEDEntry AEK-0766814-7Source
Refusal charges, in plain English
- UNAPPROVED1 refused line
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.
Questions about Magnofarma
- Is Magnofarma on an FDA import alert?
- No listing for Magnofarma appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Colombia page.
- Has FDA refused shipments from Magnofarma?
- Yes. FDA refused 1 shipment line from Magnofarma on July 10, 2026. The most recent, on July 10, 2026, was vitamin c (ascorbic acid), charged as UNAPPROVED (unapproved new drug).
- Why did FDA refuse Magnofarma's shipments?
- The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).
- What is Magnofarma's FEI number?
- Magnofarma's FDA Establishment Identifier (FEI) is 3008172752.
Buying from Magnofarma?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.